< Back to all Breaking News
TTNP
11/10/2017 06:11am
Titan Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.